跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
湯 澡薰
教授
,
醫務管理學系
合聘教授
,
全球衛生暨衛生安全碩士學位學程
合聘教授
,
全球衛生暨衛生安全博士學位學程
合聘教授
,
國際生技醫療管理博士學位學程
https://orcid.org/0000-0003-0545-1567
電子郵件
chtang
tmu.edu
tw
h-index
2477
引文
23
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1999
2024
每年研究成果
概覽
指紋
網路
專案
(18)
研究成果
(175)
資料集
(4)
類似的個人檔案
(6)
指紋
查看啟用 Chao-Hsiun Tang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Disease
25%
Rheumatoid Arthritis
25%
Comorbidity
22%
Adalimumab
22%
Etanercept
17%
Migraine
17%
Atopic Dermatitis
14%
Hemodialysis
14%
Psoriasis
14%
Biological Product
13%
Prevalence
13%
Chronic Kidney Failure
13%
Paliperidone
12%
Mortality Rate
12%
Heart Arrest
12%
Headache
11%
Risperidone
10%
Disease Modifying Antirheumatic Drug
10%
Multiple Myeloma
10%
Cardiovascular Disease
10%
Tumor Necrosis Factor
9%
Antidepressant
8%
Methotrexate
8%
Malignant Neoplasm
8%
Typical Antipsychotic
8%
Antihypertensive Agent
7%
Heart Failure
7%
Glucocorticoid
7%
Skin Cancer
7%
Amiodarone
7%
Out of Hospital Cardiac Arrest
7%
Gout
7%
Non Melanoma Skin Cancer
7%
Cardiovascular Mortality
7%
Fragility Fracture
7%
Lidocaine
7%
Myasthenia gravis
7%
Tofacitinib
7%
All Cause Mortality
6%
Hip Fracture
6%
Chronic Obstructive Lung Disease
5%
Dipeptidyl Carboxypeptidase Inhibitor
5%
Brain Ischemia
5%
Uterine Cervix Cancer
5%
Bipolar Disorder
5%
Human Papillomavirus
5%
Vaccination Policy
5%
Infection
5%
Overall Survival
5%
Medicine and Dentistry
Cohort Analysis
51%
Health Care Cost
24%
Hazard Ratio
18%
Surgeon
17%
Migraine
14%
Cesarean Section
14%
Disease
13%
Retrospective Cohort Study
12%
Malignant Neoplasm
11%
Drug Therapy
11%
Hemodialysis
11%
Cohort Effect
11%
Heart Arrest
10%
Atopic Dermatitis
10%
Cost-Effectiveness Analysis
10%
Multiple Myeloma
10%
Psoriasis
10%
Apoplexy
9%
Chronic Kidney Disease
9%
Logistic Regression Analysis
9%
Cardiovascular Disease
8%
Wart Virus
8%
Cancer Registry
8%
Paternal Age
8%
Headache
8%
Overall Survival
7%
Base
7%
Prevalence
7%
Gynecology
7%
Multivariate Logistic Regression Analysis
7%
Chemotherapy
7%
Krukenberg Tumor
7%
Pneumococcus Vaccine
7%
Glucocorticoid
7%
Non Melanoma Skin Cancer
7%
Quality of Life
7%
Breast Cancer
7%
Risperidone
7%
Skin Cancer
7%
Biological Product
7%
Childbirth
6%
ICD-9-CM
6%
Maternal Age
6%
Decision Making
6%
Health Care
6%
Proportional Hazards Model
5%
Incentive
5%
Resuscitation
5%
Patient Characteristics
5%
Chronic Obstructive Pulmonary Disease
5%
Nursing and Health Professions
National Health Insurance
40%
Cohort Analysis
26%
Drug Therapy
22%
Health Care Utilization
18%
Confidence Interval
16%
Comorbidity
14%
Rheumatoid Arthritis
14%
Public Hospital
13%
Health Service
13%
Health Care Cost
12%
Prevalence
11%
Atopic Dermatitis
10%
Hospital Accreditation
9%
Healthcare System
9%
Outpatient
8%
Outpatient Care
8%
Hospital
8%
Multivariate Logistic Regression Analysis
7%
Cesarean Section
7%
Patient Dumping
7%
Health Status
7%
Hospital Personnel
7%
Risperidone
7%
Case Management
7%
Out of Hospital Cardiac Arrest
7%
Hospital Management
7%
Amiodarone
7%
Home Care
7%
Quality of Life
7%
Uterine Cervix Cancer
7%
Economic Evaluation
7%
Lidocaine
7%
Peritoneal Dialysis
7%
Low Birth Weight
7%
Adalimumab
7%
Cost Effectiveness Analysis
7%
Sample Size
7%
Private Hospital
6%
International Classification of Diseases
6%
Independent Practice Association
6%
Disease
6%
Hazard Ratio
6%
Length of Stay
6%
Migraine
6%
Logistic Regression Analysis
6%
Hospital Readmission
5%
Hospital Administrator
5%
Teaching Hospital
5%
Resuscitation
5%
Odds Ratio
5%
